Status | Study |
RECRUITING |
Study Name: An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias Condition: Immune Thrombocytopenia Date: 2023-02-24 Interventions: Administered by subcutaneous injection every 4 weeks |
COMPLETED |
Study Name: Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim Condition: Immune Thrombocytopenia Date: 2020-11-11 Interventions: Avatrombopag 20 mg given daily for 90 days.Initial dose and dose adjustments will be determined by the physician along with the Doptelet prescri |
RECRUITING |
Study Name: Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia Condition: Immune Thrombocytopenia Date: 2019-06-17 Interventions: 45 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation |
Not yet recruiting |
Study Name: Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate Condition: Immune Thrombocytopenia Date: 2017-05-02 Interventions: Drug: Mycophenolate Mofetil 50 |
Recruiting |
Study Name: Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia Condition: Immune Thrombocytopenia Date: 2017-04-13 Interventions: Drug: Rituximab (Mabthera ®) Belimumab (Benlysta ®) Rituximab (Mabthera ®): 1g IV at W0 a |
Recruiting |
Study Name: Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia Condition: Immune Thrombocytopenia Date: 2017-01-16 Interventions: Drug: Probiotic Agent probioti |
Not yet recruiting |
Study Name: A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) Condition: Immune Thrombocytopenia Date: 2016-12-22 Interventions: Drug: Bortezomib Bortezomib was given by intravenous bolus injection at a dose of 1.3 mg/m2 on days 1, 4 |
Recruiting |
Study Name: Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) Condition: Immune Thrombocytopenia Date: 2016-08-11 Interventions: Drug: Romiplostim Drug: Placebo |
Recruiting |
Study Name: Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) Condition: Immune Thrombocytopenia (ITP) Date: 2016-08-11 Interventions: Drug: Romiplostim Other Name: AMG531 |
Recruiting |
Study Name: Immune Thrombocytopenia in Pregnancy Condition: Immune Thrombocytopenia Pregnancy Date: 2016-07-31 Interventions: Other: No intervention |